A new cancer treatment is realizing outstanding results against pancreatic
cancer. Following five weeks of treatment, a patient’s large, stage 4 tumor was
reduced in size by 70%. After seven more weeks of treatment, it no longer could
be definitely identified on scans. Pancreatic cancer usually is fatal six to
nine months after diagnosis. NeoPlas Innovation’s combination of FDA-approved
drugs appears to improve those odds for some patients, based on this result and
similar ones seen before the protocol’s public availability.

Fibromyalgia is one of those diseases that the medical world isn’t quite sure to make of. Yet, a recent study has shown that the brain behaves differently in these patients. By using single photon emission computed tomography (SPECT) scans, reaserchers found differences in the brain activity of those people with fibromyalgia. Those parts of the brain affected deal with the preception of pain and emotional responses to pain.